Drug Trial Radar · NCT07807111
Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy
Last checked: Nov 19, 2026Latest source record: Sep 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
27
Planned (sponsor's estimate)
Start
Oct 8, 2025
Primary completion
Mar 2032
Study completion Mar 2032
Sponsor
- Lead sponsor
- SparingVisionIndustry
- Sponsor type
- Industry
- First posted
- Sep 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This open-label, multi-center study is to evaluate the safety, tolerability, and efficacy of escalating doses of a gene therapy called SPVN20 administered via a single intravitreal injection in participants with advanced Rod-Cone Dystrophy.
Conditions
- Retinitis Pigmentosa (RP)
- Rod Cone Dystrophy
Interventions
SPVN20 (high dose)Biological
SPVN20
SPVN20 (medium dose)Biological
SPVN20
SPVN20 (low dose)Biological
SPVN20
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and TolerabilityTime frame: 6 months
- Ocular safetyTime frame: 6 months
Locations
3 sites in 3 countries. Site status is shown where the registry gives one.
Ghent University Hospital
Ghent, Belgium · Recruiting
CHNO XV-XX Paris - CIC 1423
Paris, France · Recruiting
Royal Victoria Eye And Ear Hospital
Dublin, Ireland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.